Price $4.91 |
Market Cap
59.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.78
|
P/S
0.28
|
Dividend %
3.00%
|
|
P/CF
32.1
|
P/FCF
29.5
|
Op. Cash Flow
5.8K
|
FCF
0.1
|
|
Op. Margin
0.40%
|
Net Margin
-0.40%
|
ROE
-2.60%
|
ROI
12.10%
|
|
ROA
-1.20%
|
EPS Growth
-110.70%
|
Current Ratio
1.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd (WVE) | $4.09 | - | - | 409.2M | Strong Buy |
| LAVA Therapeutics NV (LVTX) | $2.51 | - | - | 49.9M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $127.10 | - | - | 8.26B | Strong Buy |
| Item 9 Labs Corp (INLB) | $0.08 | - | - | 7.1M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.20 | - | - | 11.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
